- Home
- LSTA vs TOI Comparison
LSTA vs TOI Comparison
Compare LSTA & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- TOI
- Stock Information
- Founded
- LSTA 1980
- TOI 2007
- Country
- LSTA United States
- TOI United States
- Employees
- LSTA N/A
- TOI N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- TOI Medical/Nursing Services
- Sector
- LSTA Health Care
- TOI Health Care
- Exchange
- LSTA Nasdaq
- TOI Nasdaq
- Market Cap
- LSTA 24.2M
- TOI 20.1M
- IPO Year
- LSTA N/A
- TOI N/A
- Fundamental
- Price
- LSTA $2.85
- TOI $0.18
- Analyst Decision
- LSTA Strong Buy
- TOI Strong Buy
- Analyst Count
- LSTA 1
- TOI 1
- Target Price
- LSTA $15.00
- TOI $2.50
- AVG Volume (30 Days)
- LSTA 15.2K
- TOI 297.4K
- Earning Date
- LSTA 11-12-2024
- TOI 11-13-2024
- Dividend Yield
- LSTA N/A
- TOI N/A
- EPS Growth
- LSTA N/A
- TOI N/A
- EPS
- LSTA N/A
- TOI N/A
- Revenue
- LSTA N/A
- TOI $378,933,000.00
- Revenue This Year
- LSTA N/A
- TOI $29.17
- Revenue Next Year
- LSTA N/A
- TOI $16.43
- P/E Ratio
- LSTA N/A
- TOI N/A
- Revenue Growth
- LSTA N/A
- TOI 22.29
- 52 Week Low
- LSTA $2.05
- TOI $0.18
- 52 Week High
- LSTA $3.83
- TOI $2.50
- Technical
- Relative Strength Index (RSI)
- LSTA 46.05
- TOI 24.09
- Support Level
- LSTA $2.75
- TOI $0.25
- Resistance Level
- LSTA $2.94
- TOI $0.30
- Average True Range (ATR)
- LSTA 0.21
- TOI 0.04
- MACD
- LSTA -0.01
- TOI -0.01
- Stochastic Oscillator
- LSTA 23.08
- TOI -0.06
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.